XELOX + BEV regimen | XELOX regimen | |||||||
<70 Years (n = 26) | ≥70 Years (n = 20) | <70 Years (n = 19) | ≥70 Years (n = 14) | |||||
n | % | n | % | n | % | n | % | |
Complete response | 2 | (7.7%) | 1 | (5.0%) | 0 | (0.0%) | 0 | (0.0%) |
Partial response | 6 | (23.1%) | 7 | (35.0%) | 3 | (15.8%) | 2 | (14.3%) |
Stable disease | 11 | (42.3%) | 10 | (50.0%) | 7 | (36.8%) | 2 | (14.3%) |
Progressive disease | 0 | (0.0%) | 2 | (10.0%) | 2 | (10.5%) | 3 | (21.4%) |
Not evaluated | 7 | (26.9%) | 0 | (0.0%) | 7 | (36.8%) | 7 | (50.0%) |